ロード中...
Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design
The rapidly emerging field of immunotherapy and the development of novel immunologic agents that have been approved in melanoma and successfully studied in lung cancer, kidney cancer, and prostate cancer have mandated that there be uniformity in clinical trial analysis beyond conventional survival e...
保存先:
| 出版年: | Immunotargets Ther |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918229/ https://ncbi.nlm.nih.gov/pubmed/27471695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S30821 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|